-
-
-
-
-
-
-
Xilio presents preclinical data on masked immunotherapy programs at SITC
-
-
-
-
-
-
-
AbbVie (ABBV) and Xilio Therapeutics (XLO) Announce Collaboration and Option Agreement to Develop Novel Tumor-Activated Immunotherapies
-
-
-
-
-
-
-
Xilio Therapeutics (XLO) Appoints Aoife Brennan and James Shannon to its Board
460,934 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

